DARPP-32 and modulation of cAMP signaling: involvement in motor control and levodopa-induced dyskinesia.

The dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32) is abundantly expressed in the medium spiny neurons of the striatum. Phosphorylation catalysed by cAMP-dependent protein kinase (PKA) converts DARPP-32 into an inhibitor of protein phosphatase-1. In contrast, phosphorylation catalysed by cyclin dependent kinase-5 on Thr75 converts DARPP-32 into an inhibitor of PKA. Changes in the state of phosphorylation of DARPP-32 reinforce the behavioral effects produced by stimulation or inhibition of the cAMP pathway. Dopamine, via D(1) receptors, and adenosine, via A(2A) receptors, affect motor behavior by acting on medium spiny neurons, via G(olf) mediated stimulation of the cAMP signaling cascade. The involvement of DARPP-32 in dopamine and adenosine transmission and the possible role played by abnormal regulation of DARPP-32 phosphorylation in levodopa-induced dyskinesia are discussed.

[1]  C. Gerfen,et al.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. , 1990, Science.

[2]  M. Iadarola,et al.  Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Greengard,et al.  A Dopamine/D1 Receptor/Protein Kinase A/Dopamine- and cAMP-Regulated Phosphoprotein (Mr 32 kDa)/Protein Phosphatase-1 Pathway Regulates Dephosphorylation of the NMDA Receptor , 1998, The Journal of Neuroscience.

[4]  Sl Harris.  Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartment and limbic subdivisions of the striatum , 1990 .

[5]  P. Greengard,et al.  Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons , 1995, Neuron.

[6]  P. Greengard,et al.  Amplification of dopaminergic signaling by a positive feedback loop. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Greengard,et al.  D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade. , 2000, Journal of neurophysiology.

[8]  H. Usui,et al.  Three distinct forms of type 2A protein phosphatase in human erythrocyte cytosol. , 1988, The Journal of biological chemistry.

[9]  P. Greengard,et al.  Bidirectional Regulation of DARPP-32 Phosphorylation by Dopamine , 1997, The Journal of Neuroscience.

[10]  R. Hen,et al.  G OLFa Mediates Dopamine D 1 Receptor Signaling , 2000 .

[11]  J. Vanderhaeghen,et al.  Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  P. Greengard,et al.  Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  B. Fredholm,et al.  Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. , 1999, Pharmacological reviews.

[14]  P. Greengard,et al.  Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons , 1998, Neuroscience.

[15]  S. Schiffmann,et al.  Striatal Restricted Adenosine A2 Receptor (RDC8) Is Expressed by Enkephalin but Not by Substance P Neurons: An In Situ Hybridization Histochemistry Study , 1991, Journal of neurochemistry.

[16]  P. Greengard,et al.  DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1 , 1984, Nature.

[17]  P. Greengard,et al.  Beyond the Dopamine Receptor: Review the DARPP-32/Protein Phosphatase-1 Cascade , 1999 .

[18]  O. Andreassen,et al.  Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine , 2000, The Journal of Neuroscience.

[19]  P. Svenningsson,et al.  Distribution, biochemistry and function of striatal adenosine A2A receptors , 1999, Progress in Neurobiology.

[20]  A. Fienberg,et al.  Gαolf Levels Are Regulated by Receptor Usage and Control Dopamine and Adenosine Action in the Striatum , 2001, The Journal of Neuroscience.

[21]  P. Calabresi,et al.  Long‐term Potentiation in the Striatum is Unmasked by Removing the Voltage‐dependent Magnesium Block of NMDA Receptor Channels , 1992, The European journal of neuroscience.

[22]  P. Greengard,et al.  Regulation of Phosphorylation of the GluR1 AMPA Receptor in the Neostriatum by Dopamine and Psychostimulants In Vivo , 2000, The Journal of Neuroscience.

[23]  A. Graybiel,et al.  Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Greengard,et al.  Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons , 1999, Nature.

[25]  E. M. Adler,et al.  Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. , 1992, Brain research. Molecular brain research.

[26]  M. Umemiya,et al.  Dopaminergic modulation of excitatory postsynaptic currents in rat neostriatal neurons. , 1997, Journal of neurophysiology.

[27]  Paul Greengard,et al.  Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen , 1998, Brain Research.

[28]  J A Obeso,et al.  Preventing levodopa-induced dyskinesias. , 2000, Annals of neurology.

[29]  H. Hayashi,et al.  Activation of protein phosphatase 2A by cAMP‐dependent protein kinase‐catalyzed phosphorylation of the 74‐kDa B″ (δ) regulatory subunit in vitro and identification of the phosphorylation sites , 1998, FEBS letters.

[30]  Paul Greengard,et al.  DARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission , 1998 .

[31]  Erwan Bezard,et al.  Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies , 2001, Nature Reviews Neuroscience.

[32]  Paul Greengard,et al.  Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia , 2003, Nature Neuroscience.

[33]  P. Greengard,et al.  Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine , 2002, Nature.

[34]  J. Bargas,et al.  Dopamine facilitates striatal EPSPs through an L‐type Ca2+ conductance , 1997, Neuroreport.

[35]  C. Gerfen.  The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. , 1992, Annual review of neuroscience.

[36]  P. Greengard,et al.  Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5 , 2001, Nature.